IMMUNOCOV Trademark

Trademark Overview


On Wednesday, May 6, 2020, a trademark application was filed for IMMUNOCOV with the United States Patent and Trademark Office. The USPTO has given the IMMUNOCOV trademark a serial number of 88902703. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, November 30, 2020. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The IMMUNOCOV trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease antibody detection, namely, for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples
immunocov

General Information


Serial Number88902703
Word MarkIMMUNOCOV
Filing DateWednesday, May 6, 2020
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, November 30, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements


Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease antibody detection, namely, for identifying antibodies that neutralize the SARS-CoV-2 virus in patient blood samples

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, November 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Monday, November 30, 2020ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Monday, November 30, 2020ABANDONMENT - AFTER PUBLICATION
Tuesday, November 24, 2020TEAS EXPRESS ABANDONMENT RECEIVED
Wednesday, October 7, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 27, 2020ASSIGNED TO EXAMINER
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Thursday, July 23, 2020ASSIGNED TO EXAMINER
Monday, May 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 9, 2020NEW APPLICATION ENTERED IN TRAM